Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study
Pradeep S. Chauhan, Kevin Chen, Ramandeep K. Babbra, et al.
PLoS Medicine (2021) Vol. 18, Iss. 8, pp. e1003732-e1003732
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Circulating Tumor DNA Minimal Residual Disease Detection of Non–Small-Cell Lung Cancer Treated With Curative Intent
Bruna Pellini, Aadel A. Chaudhuri
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 567-575
Open Access | Times Cited: 134
Urine biomarkers in bladder cancer — current status and future perspectives
Moritz Maas, Tilman Todenhöfer, Peter C. Black
Nature Reviews Urology (2023) Vol. 20, Iss. 10, pp. 597-614
Closed Access | Times Cited: 59
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients
Pradeep S. Chauhan, Alexander L. Shiang, Irfan Alahi, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 46
A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
Milena Matuszczak, Adam Kiljańczyk, Maciej Salagierski
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8597-8597
Open Access | Times Cited: 41
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
Emil Christensen, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 8, pp. 1582-1591
Open Access | Times Cited: 37
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 37
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
Kyle Rose, Heather L. Huelster, Joshua J. Meeks, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 7, pp. 406-419
Closed Access | Times Cited: 33
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006284-e006284
Open Access | Times Cited: 31
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer
Trine Strandgaard, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.
European Urology (2023) Vol. 85, Iss. 1, pp. 82-92
Open Access | Times Cited: 20
Advancements in Urothelial Cancer Care: Optimizing Treatment for Your Patient
Gregory Hemenway, Jonathan F. Anker, Paul Riviere, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 5
The Bridge: Supernatant Derived From Cytological Sample Preparations
Sinchita Roy‐Chowdhuri
Cytopathology (2025)
Closed Access
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder
Lucas Motta Martinez, Letícia Carina Ribeiro, Roberto Guidi, et al.
Current Oncology Reports (2025)
Closed Access
Development of a technique for diagnosis and screening of superficial bladder cancer by cell-pellet DNA from urine sample
Jaekwon Seok, Hee Jeong Kwak, Chan-Koo Kang, et al.
Laboratory Investigation (2025), pp. 104124-104124
Closed Access
Molecular testing in urinary cytology specimens: Current status and future directions
Fei Chen, Aylin Simsir, Liang Cheng
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Emerging Proximal Liquid Biopsy Approaches for Detecting Residual Disease and Predicting Recurrence in Head and Neck Cancer: A Review and Proposal of Novel Liquid Staging
Vanessa Helou, Joshua D. Smith, Micah Harris, et al.
Head & Neck (2025)
Open Access
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors
Kevin Chen, Misty Dawn Shields, Pradeep S. Chauhan, et al.
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 6, pp. 757-774
Open Access | Times Cited: 32
Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations
Hye Won Lee, Whi‐An Kwon, La Ngoc Thu Nguyen, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1323-1323
Open Access | Times Cited: 11
A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues
Yi‐Hsiang Huang, Chengxiao Liao, Zefeng Shen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy
Di Xiao, Xin Hu, Mei Peng, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 16
Recent development of urinary biomarkers for bladder cancer diagnosis and monitoring
Yuchen Zeng, Anqi Wang, Wei Lv, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 2
Open Access | Times Cited: 10
Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology
Noah Earland, Kevin Chen, Nicholas P. Semenkovich, et al.
Seminars in Radiation Oncology (2023) Vol. 33, Iss. 3, pp. 262-278
Closed Access | Times Cited: 10
Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications
Siyu Wu, Rong Li, Yuan‐Hong Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115027-115027
Open Access | Times Cited: 10
Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges
Gang Wang, Wan Jin, Zilin Xu, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Honing the Hunt: A Comprehensive Review of Cell-free Tumor DNA to Predict Neoadjuvant Therapy Efficacy in Bladder Cancer
Caio Vinícius Suartz, Lucas Motta Martinez, Maurício Cordeiro, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 3, pp. 102087-102087
Closed Access | Times Cited: 3
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer
Joshua Linscott, Hiroko Miyagi, Prithvi Murthy, et al.
Current Oncology Reports (2024)
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top